Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1
Over the next 30 days, Ill be paying close attention to how my body feels particularly regarding digestive comfort, fluid balance, and any shifts in my metabolism or energy
Weight loss and appetite reduction are the expected outcomes of GLP-1 medications 3 , but it is important to lose weight in a healthy manner
Benefits and Risks to Consider The potential benefits of GLP-1 Microdosing include improved tolerability, sustained adherence, cost savings, and flexibility in managing diverse patient populations
Shah says
8f) in fibroblasts were effectively suppressed by liraglutide